Eupraxia Pharmaceuticals Releases 'Positive' Additional Data From Study of Eosinophilic Esophagitis Drug Candidate
Eupraxia Pharmaceuticals Releases 'Positive' Additional Data From Study of Eosinophilic Esophagitis Drug Candidate
Eupraxia制药发布了有关嗜酸性食道炎药物候选研究的"积极"额外数据
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间